AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 49 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,787,336 | -13.8% | 767,097 | -11.9% | 0.00% | – |
| Q2 2023 | $2,072,966 | +27.2% | 870,994 | -1.6% | 0.00% | – |
| Q1 2023 | $1,629,315 | +108.0% | 885,497 | +114.8% | 0.00% | – |
| Q4 2022 | $783,275 | -18.1% | 412,250 | -7.7% | 0.00% | – |
| Q3 2022 | $956,000 | -27.8% | 446,855 | -4.5% | 0.00% | – |
| Q2 2022 | $1,325,000 | -17.8% | 467,846 | +21.0% | 0.00% | – |
| Q1 2022 | $1,612,000 | -34.2% | 386,714 | -18.0% | 0.00% | – |
| Q4 2021 | $2,448,000 | +149.0% | 471,733 | +214.5% | 0.00% | – |
| Q3 2021 | $983,000 | +170.1% | 149,972 | +173.5% | 0.00% | – |
| Q2 2021 | $364,000 | -78.7% | 54,841 | -81.6% | 0.00% | – |
| Q1 2021 | $1,705,000 | -36.5% | 297,605 | -0.9% | 0.00% | – |
| Q4 2020 | $2,684,000 | -29.3% | 300,260 | -7.9% | 0.00% | – |
| Q3 2020 | $3,795,000 | -32.4% | 326,090 | -6.8% | 0.00% | – |
| Q2 2020 | $5,611,000 | +312.9% | 350,046 | +54.3% | 0.00% | – |
| Q1 2020 | $1,359,000 | -57.5% | 226,867 | -6.5% | 0.00% | – |
| Q4 2019 | $3,201,000 | -0.4% | 242,510 | -6.3% | 0.00% | – |
| Q3 2019 | $3,213,000 | -0.6% | 258,724 | +28.8% | 0.00% | – |
| Q2 2019 | $3,234,000 | -45.7% | 200,872 | +6.2% | 0.00% | – |
| Q1 2019 | $5,951,000 | -10.7% | 189,070 | -6.8% | 0.00% | – |
| Q4 2018 | $6,666,000 | +4314.6% | 202,973 | +4011.3% | 0.00% | – |
| Q3 2018 | $151,000 | +14.4% | 4,937 | 0.0% | 0.00% | – |
| Q2 2018 | $132,000 | – | 4,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |